Patents by Inventor Hakan Eriksson

Hakan Eriksson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Network architecture, methods, and devices for a wireless communications network
    Patent number: 12231284
    Abstract: Methods and apparatus in a fifth-generation wireless communications network, including an example method, in a wireless device, that includes determining a reporting quality threshold for a parameter related to channel state information (CSI); performing a measurement for each of a plurality of beams from a first predetermined set of beams for evaluation; evaluating the measurement for each of the plurality of beams against the reporting quality threshold; discontinuing the performing and evaluating of measurements in response to determining that the reporting quality threshold is met for one of the beams, such that one or more beams in the first predetermined set of beams are not measured and evaluated; and reporting, to the wireless communications network, CSI for the one of the beams.
    Type: Grant
    Filed: June 8, 2022
    Date of Patent: February 18, 2025
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Stefan Parkvall, Janne Peisa, Gunnar Mildh, Robert Baldemair, Stefan Wager, Jonas Kronander, Karl Werner, Richard Abrahamsson, Ismet Aktas, Peter Alriksson, Junaid Ansari, Shehzad Ali Ashraf, Henrik Asplund, Fredrik Athley, Håkan Axelsson, Joakim Axmon, Johan Axnäs, Kumar Balachandran, Gunnar Bark, Jan-Erik Berg, Andreas Bergström, Håkan Björkegren, Nadia Brahmi, Cagatay Capar, Anders Carlsson, Andreas Cedergren, Mikael Coldrey, Icaro L. J. da Silva, Erik Dahlman, Ali El Essaili, Ulrika Engström, Mårten Ericson, Erik Eriksson, Mikael Fallgren, Rui Fan, Gabor Fodor, Pål Frenger, Jonas Fridén, Jonas Fröberg Olsson, Anders Furuskär, Johan Furuskog, Virgile Garcia, Ather Gattami, Fredrik Gunnarsson, Ulf Gustavsson, Bo Hagerman, Fredrik Harrysson, Ning He, Martin Hessler, Kimmo Hiltunen, Songnam Hong, Dennis Hui, Jörg Huschke, Tim Irnich, Sven Jacobsson, Niklas Jaldén, Simon Järmyr, Zhiyuan Jiang, Martin Johansson, Niklas Johansson, Du Ho Kang, Eleftherios Karipidis, Patrik Karlsson, Ali S. Khayrallah, Caner Kilinc, Göran N. Klang, Sara Landström, Christina Larsson, Gen Li, Bo Lincoln, Lars Lindbom, Robert Lindgren, Bengt Lindoff, Fredrik Lindqvist, Jinhua Liu, Thorsten Lohmar, Qianxi Lu, Lars Manholm, Ivana Maric, Jonas Medbo, Qingyu Miao, Reza Moosavi, Walter Müller, Elena Myhre, Johan Nilsson, Karl Norrman, Bengt-Erik Olsson, Torgny Palenius, Sven Petersson, Jose Luis Pradas, Mikael Prytz, Olav Queseth, Pradeepa Ramachandra, Edgar Ramos, Andres Reial, Thomas Rimhagen, Emil Ringh, Patrik Rugeland, Johan Rune, Joachim Sachs, Henrik Sahlin, Vidit Saxena, Nima Seifi, Yngve Selén, Eliane Semaan, Sachin Sharma, Cong Shi, Johan Sköld, Magnus Stattin, Anders Stjernman, Dennis Sundman, Lars Sundström, Miurel Isabel Tercero Vargas, Claes Tidestav, Sibel Tombaz, Johan Torsner, Hugo Tullberg, Jari Vikberg, Peter von Wrycza, Thomas Walldeen, Anders Wallen, Pontus Wallentin, Hai Wang, Ke Wang Helmersson, Jianfeng Wang, Yi-Pin Eric Wang, Niclas Wiberg, Emma Wittenmark, Osman Nuri Can Yilmaz, Ali Zaidi, Zhan Zhang, Zhang Zhang, Yanli Zheng
  • USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSTEM ATROPHY (MSA) 938
    Publication number: 20200405724
    Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
    Type: Application
    Filed: September 13, 2020
    Publication date: December 31, 2020
    Inventors: Hakan Eriksson, Werner Poewe
  • Use of myeloperoxidase (MPO) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (MSA) 938
    Patent number: 10772890
    Abstract: The present invention relates to the use of myeloperoxidase inhibitors (MPO) inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: September 15, 2020
    Assignee: AstraZeneca AB
    Inventors: Hakan Eriksson, Werner Poewe
  • Method, system and device for inter-frequency load balancing in a mobile telecommunications network
    Patent number: 10595230
    Abstract: A method, system and device load balancing in a telecommunications network is provided where a selection of one or more User Equipments (UEs), to be relocated from a source cell to a target cell is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured and fed back by the target cell radio base station (RBS) to the source cell RBS, and used for updating the predicted performance value.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: March 17, 2020
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Sven Ekemark, Håkan Eriksson, Lena Melin
  • USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSTEM ATROPHY (MSA) 938
    Publication number: 20190099423
    Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
    Type: Application
    Filed: August 30, 2018
    Publication date: April 4, 2019
    Inventors: Hakan Eriksson, Werner Poewe
  • Method, System and Device for Inter-Frequency Load Balancing in a Mobile Telecommunications Network
    Publication number: 20170367011
    Abstract: A method, system and device load balancing in a telecommunications network is provided where a selection of one or more User Equipments (UEs), to be relocated from a source cell to a target cell is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured and fed back by the target cell radio base station (RBS) to the source cell RBS, and used for updating the predicted performance value.
    Type: Application
    Filed: August 30, 2017
    Publication date: December 21, 2017
    Inventors: Sven Ekemark, Håkan Eriksson, Lena Melin
  • Method, system and device for inter-frequency load balancing in a mobile telecommunications network
    Patent number: 9820188
    Abstract: A method, system and device load balancing in a telecommunications network is provided where the selection of the one or more User Equipment (UE) 150, to be relocated from a source cell 112 to a target cell 122, is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured actually and fed back 312 by the target cell RBS 120 to the source cell RBS 110, and used for updating the predicted performance value.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: November 14, 2017
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Sven Ekemark, Håkan Eriksson, Lena Melin
  • Method, System and Device for Inter-Frequency Load Balancing in a Mobile Telecommunications Network
    Publication number: 20160277968
    Abstract: A method, system and device load balancing in a telecommunications network is provided where the selection of the one or more User Equipment (UE) 150, to be relocated from a source cell 112 to a target cell 122, is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured actually and fed back 312 by the target cell RBS 120 to the source cell RBS 110, and used for updating the predicted performance value.
    Type: Application
    Filed: October 2, 2014
    Publication date: September 22, 2016
    Inventors: Sven Ekemark, Håkan Eriksson, Lena Melin
  • Device and method for determination of an analyte in blood
    Patent number: 9347958
    Abstract: A sample acquiring device, an apparatus and a method for spectrophotometric measurement of high density lipoprotein (HDL) and at least one of total cholesterol (TC), triglycerides (TG) and glucose (FPG).
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: May 24, 2016
    Assignee: HemoCue AB
    Inventors: Malin Jonsson, Ekaterina Riabova, Hakan Eriksson, Johan Folkesson
  • DEVICE AND METHOD FOR DETERMINATION OF AN ANALYTE IN BLOOD
    Publication number: 20150377913
    Abstract: A sample acquiring device, an apparatus and a method for spectrophotometric measurement of high density lipoprotein (HDL) and at least one of total cholesterol (TC), triglycerides (TG) and glucose (FPG).
    Type: Application
    Filed: June 27, 2014
    Publication date: December 31, 2015
    Applicant: HemoCue AB
    Inventors: Malin JONSSON, Ekaterina RIABOVA, Hakan ERIKSSON, Johan FOLKESSON
  • USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSYEM ATROPHY (MSA) 938
    Publication number: 20140221400
    Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
    Type: Application
    Filed: November 8, 2013
    Publication date: August 7, 2014
    Applicant: ASTRAZENECA AB
    Inventors: Hakan Eriksson, Werner Poewe
  • USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSYEM ATROPHY (MSA) 938
    Publication number: 20110207755
    Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
    Type: Application
    Filed: February 23, 2011
    Publication date: August 25, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Håkan Eriksson, Werner Poewe
  • ANTIGEN EXPOSING MICELLE AND UNORDERED AGGREGATE
    Publication number: 20100291705
    Abstract: An antigen exposing micelle or unordered aggregate comprising at least one carrier, at least one epitope and at least one anchoring molecule, wherein said anchoring molecule comprises at least one anchoring part, intended to anchor the antigen exposing micelle to a surface.
    Type: Application
    Filed: July 10, 2008
    Publication date: November 18, 2010
    Applicant: EURO-DIAGNOSTICA AB
    Inventors: Laura Varas, Anna Ketelsen, Hakan Eriksson
  • Pre-alignment outside an antenna measurement range
    Patent number: 7667656
    Abstract: A method is disclosed for optically pre-aligning and referencing an antenna set-up outside an antenna measurement range. The pre-alignment is performed in an integration room close to the antenna measurement range in order to avoid unnecessary occupation of the measurement range. The method teaches a technique using generally a pair of high accuracy theodolites (T1, T2) to by means of a room mirror reference (RM) and an antenna mirror-cube transfer a difference between the co-ordinate system of an integration tower (INT) used and the measurement range antenna tower.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: February 23, 2010
    Assignee: Telefonaktiebolaget L M Ericsson (Publ)
    Inventor: Mats Gunnar Hakan Eriksson
  • Pre-Alignment Outside An Antenna Measurement Range
    Publication number: 20090073061
    Abstract: A method is disclosed for optically pre-aligning and referencing an antenna set-up outside an antenna measurement range. The pre-alignment is performed in an integration room close to the antenna measurement range in order to avoid unnecessary occupation of the measurement range. The method teaches a technique using generally a pair of high accuracy theodolites (T1, T2) to by means of a room mirror reference (RM) and an antenna mirror-cube transfer a difference between the co-ordinate system of an integration tower (INT) used and the measurement range antenna tower.
    Type: Application
    Filed: September 30, 2004
    Publication date: March 19, 2009
    Inventor: Mats Gunnar Hakan Eriksson
  • System and Method for Activity-Based Power Control Target Adjustments in a Wireless Communication Network
    Publication number: 20090061886
    Abstract: The teachings presented herein provide, among other things, improved power control stability and increased system capacity in a wireless communication network by raising signal quality targets for mobile stations engaged in scheduled uplink data transmissions and lowering those signal quality targets at the end of such transmissions. As one example, the teachings herein are applied to the Enhanced Uplink (EUL) in a Wideband CDMA (WCDMA) network. In that context, the target received signal quality (e.g., SIR) for a given mobile station's Dedicated Physical Control Channel (DPCCH) signal is raised for times when the mobile station is engaged in a scheduled data transmission via its Enhanced-Dedicated Physical Data Channel (E-DPDCH), and lowered at other times. Doing so prevents the power control loop from “chasing” the potentially dramatic changes in mobile-specific interference conditions that arise in a scheduled uplink environment.
    Type: Application
    Filed: August 29, 2007
    Publication date: March 5, 2009
    Inventors: Carmela Cozzo, Christer Edholm, Hakan Eriksson
  • New Combination 937
    Publication number: 20090053176
    Abstract: The present invention related to a combination of (a) a compound which is a MPO inhibitor or a pharmaceutically acceptable salt thereof and (b) a compound or a pharmaceutically acceptable salt thereof, which is used in the treatment and/or prevention of PD or Multiple Sclerosis. The invention further relates to pharmaceutical compositions comprising said combination and to methods of treating Neuroinflammatory and Neurodegenerative Disorder(s), such as PD and Multiple Sclerosis in mammals by administrating said combination. The invention further relates to a kit comprising the combination and use of said kit in treatment of Neuroinflammatory Disorder(s).
    Type: Application
    Filed: August 21, 2008
    Publication date: February 26, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Gabrielle Ahlberg, Hakan Eriksson
  • New Use 938
    Publication number: 20090054468
    Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
    Type: Application
    Filed: August 21, 2008
    Publication date: February 26, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Hakan Eriksson, Werner Poewe
  • Analyzer
    Patent number: D746999
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: January 5, 2016
    Assignee: HemoCue AB
    Inventors: Malin Jonsson, Ekaterina Riabova, Hakan Eriksson, Johan Folkesson
  • Sampling device
    Patent number: D784554
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: April 18, 2017
    Assignee: HemoCue AB
    Inventors: Malin Jonsson, Ekaterina Riabova, Hakan Eriksson, Johan Folkesson